| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.96B | 28.53B | 26.55B | 24.63B | 21.72B | 19.54B |
| Gross Profit | 7.23B | 6.82B | 5.68B | 5.02B | 4.68B | 4.30B |
| EBITDA | 2.91B | 2.64B | 1.94B | 1.55B | 1.44B | 1.39B |
| Net Income | -297.87M | -628.78M | 268.87M | 60.14M | -82.14M | 633.12M |
Balance Sheet | ||||||
| Total Assets | 29.67B | 28.51B | 28.46B | 26.47B | 25.21B | 23.73B |
| Cash, Cash Equivalents and Short-Term Investments | 5.00B | 4.62B | 5.23B | 3.85B | 3.18B | 3.90B |
| Total Debt | 14.84B | 13.96B | 13.02B | 12.85B | 11.19B | 10.84B |
| Total Liabilities | 21.24B | 20.41B | 20.17B | 19.25B | 18.29B | 17.41B |
| Stockholders Equity | 8.43B | 8.09B | 8.29B | 7.22B | 6.92B | 6.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.59B | 1.57B | -869.02M | -795.41M | 455.54M |
| Operating Cash Flow | 0.00 | 509.02M | 2.05B | 279.37M | 945.12M | 1.40B |
| Investing Cash Flow | 0.00 | -1.30B | -667.43M | -1.60B | -1.56B | 327.05M |
| Financing Cash Flow | 0.00 | 912.72M | -445.05M | 1.45B | -169.44M | -753.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥28.59B | 7.77 | ― | 2.76% | 7.69% | -0.40% | |
77 Outperform | ¥21.89B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
73 Outperform | ¥13.34B | 44.98 | ― | 3.84% | 5.57% | 89.21% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥6.80B | 5.29 | ― | 3.91% | 21.23% | -112.48% | |
57 Neutral | ¥6.96B | 8.05 | 3.72% | 1.17% | 7.68% | ― | |
55 Neutral | ¥7.83B | 67.72 | ― | 5.64% | -0.91% | -319.62% |